Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia

AIDS Research and Human Retroviruses

Volumn 27, Issue 4, 2011, Pages 391-398

  Yang, Otto O ^a   Daar, Eric S ^a   Ng, Hwee L ^a   Shih, Roger ^a   Jamieson, Beth D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAG PROTEIN; NEF PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; VIREMIA;

CD8-POSITIVE T-LYMPHOCYTES; CONSERVED SEQUENCE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES, T-LYMPHOCYTE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VIREMIA;

EID: 79953736214     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0183     Document Type: Article

References (39)

1. Yang OO: Will we be able to 'spot' an effective HIV-1 vaccine? Trends Immunol 2003;24:67-72.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110. (Pubitemid 24258634)
3. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655. (Pubitemid 24183063)
4. Jin X, Bauer DE, Tuttleton SE, et al.: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189:991-998. (Pubitemid 29149355)
5. Matano T, Shibata R, Siemon C, Connors M, Lane HC, and Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72:164-169. (Pubitemid 28048825)
6. Schmitz JE, Kuroda MJ, Santra S, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
7. Rolland M, Heckerman D, Deng W, et al.: Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS ONE 2008;3:e1424.
8. Kiepiela P, Ngumbela K, Thobakgale C, et al.: CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007;13:46-53. (Pubitemid 46067385)
9. Masemola A, Mashishi T, Khoury G, et al.: Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: Correlation with viral load. J Virol 2004;78:3233-3243. (Pubitemid 38568263)
10. Riviere Y, McChesney MB, Porrot F, et al.: Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995;11:903-907.
11. Yang OO, Kalams SA, Rosenzweig M, et al.: Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol 1996;70:5799-5806. (Pubitemid 26266788)
12. Yang OO, Kalams SA, Trocha A, et al.: Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 1997;71:3120-3128. (Pubitemid 27119959)
13. Chen H, Piechocka-Trocha A, Miura T, et al.: Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes. J Virol 2009;83:3138-3149.
14. Goulder PJ, Altfeld MA, Rosenberg ES, et al.: Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001;193:181-194.
15. Yang OO: Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes. AIDS 30 2008;22:325-331.
16. Koibuchi T, Allen TM, Lichterfeld M, et al.: Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection. J Virol 2005;79:8171-8181. (Pubitemid 40853520)
17. Ibarrondo FJ, Anton PA, Fuerst M, et al.: Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection. J Virol 2005;79:4289-4297. (Pubitemid 40388366)
18. Balamurugan A, Lewis MJ, Kitchen CM, et al.: Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol 2008;82:2784-2791. (Pubitemid 351329169)
19. Yang OO, Church J, Kitchen CM, et al.: Genetic and stochastic influences on the interaction of human immunode- ficiency virus type 1 and cytotoxic T lymphocytes in identical twins. J Virol 2005;79:15368-15375. (Pubitemid 43032319)
20. Yang OO, Daar ES, Jamieson BD, et al.: Human immunodeficiency virus type 1 clade B superinfection: Evidence for differential immune containment of distinct clade B strains. J Virol 2005;79:860-868. (Pubitemid 40053869)
21. Jones N, Agrawal D, Elrefaei M, et al.: Evaluation of antigen-specific responses using in vitro enriched T cells. J Immunol Methods 2003;274:139-147. (Pubitemid 36263050)
22. Liu Y, McNevin J, Cao J, et al.: Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 2006;80:9519-9529. (Pubitemid 44435628)
23. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211. (Pubitemid 27064706)
24. Price DA, Goulder PJ, Klenerman P, et al.: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-1895. (Pubitemid 27113932)
25. Jones NA, Wei X, Flower DR, et al.: Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 2004;200:1243-1256. (Pubitemid 39552566)
26. Allen TM, Altfeld M, Geer SC, et al.: Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005;79:13239-13249. (Pubitemid 41508139)
27. van der Most RG, Sette A, Oseroff C, et al.: Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol 1996;157:5543-5554. (Pubitemid 126448976)
28. Jamieson BD, Yang OO, Hultin L, et al.: Epitope escape mutation and decay of human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses. J Immunol 2003;171:5372-5379. (Pubitemid 37432823)
29. Yang OO: Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation. PLoS ONE 2009;4:e7388.
30. Altfeld M, Rosenberg ES, Shankarappa R, et al.: Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J ExpMed 2001;193:169-180. (Pubitemid 32524449)
31. Jacks T, Power MD, Masiarz FR, Luciw PA, Barr PJ, and Varmus HE: Characterization of ribosomal frame-shifting in HIV-1 gag-pol expression. Nature 1988;331:280-283. (Pubitemid 18040598)
32. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, and Eisen HN: Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med 1994;180:1283-1293. (Pubitemid 24289602)
33. Klenerman P and Zinkernagel RM: Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998;394:482-485. (Pubitemid 28373959)
34. Veazey RS, DeMaria M, Chalifoux LV, et al.: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998;280:427-431. (Pubitemid 28208163)
35. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, and Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005;434:1093-1097. (Pubitemid 40663481)
36. Brenchley JM, Schacker TW, Ruff LE, et al.: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med S 2004;200:749-759. (Pubitemid 39299461)
37. Kalams SA, Buchbinder SP, Rosenberg ES, et al.: Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 1999;73:6715-6720. (Pubitemid 29327854)
38. Wang YE, Li B, Carlson JM, et al.: Protective HLA class I alleles restricting acute-phase CD8+ T cell responses are associated with viral escape mutations located in highly conserved regions of HIV-1. J Virol 2009;83:1845-1855.
39. Heckerman D, Frahm N, Pereyra F, et al.: Vaccine-induced targeting of epitopes associated with spontaneous control of HIV viral replication is associated with lower set-point viral loads in HIV-infected participants from the STEP trial. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections (2009), 2009; Montreal, Canada.